Bcs Wealth Management Eli Lilly & CO Transaction History

Bcs Wealth Management

$312 Million
Q1 2024

A detailed history of Bcs Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Bcs Wealth Management holds 4,470 shares of LLY stock, worth $4.05 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

4,470

Previous 3,957 12.96%

Holding current value

$4.05 Million

Previous $2.31 Million 50.76%

% of portfolio

1.12%

Previous 0.85%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	BUY	$592.2 - $792.28 $303,798 - $406,439	513 Added 12.96%	4,470 $3.48 Million
Q3 2023 Oct 12, 2023	BUY	$434.7 - $599.3 $1.72 Million - $2.37 Million	3,957 New	3,957 $2.13 Million
Q1 2023 Apr 10, 2023	SELL	$310.63 - $364.82 $8,697 - $10,214	-28 Reduced 0.71%	3,898 $1.34 Million
Q3 2022 Oct 07, 2022	SELL	$296.48 - $337.87 $17,788 - $20,272	-60 Reduced 1.51%	3,926 $1.27 Million
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $16,445 - $19,308	59 Added 1.5%	3,986 $1.29 Million

Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $456,941 - $567,862	-1,947 Reduced 33.15%	3,927 $1.13 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $208,211 - $258,391	926 Added 18.71%	5,874 $1.62 Million
Q3 2021 Oct 25, 2021	BUY	$221.6 - $272.71 $1,551 - $1,908	7 Added 0.14%	4,948 $1.14 Million
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $722 - $934	4 Added 0.08%	4,941 $1.13 Million
Q1 2021 Apr 28, 2021	BUY	$164.32 - $212.72 $657 - $850	4 Added 0.08%	4,937 $922,000
Q4 2020 Jan 21, 2021	BUY	$130.46 - $172.63 $3,913 - $5,178	30 Added 0.61%	4,933 $833,000
Q3 2020 Oct 23, 2020	BUY	$146.22 - $169.13 $731 - $845	5 Added 0.1%	4,903 $726,000
Q1 2020 Apr 10, 2020	BUY	$119.05 - $147.35 $583,106 - $721,720	4,898 New	4,898 $679,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bcs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bcs Wealth Management with notifications on news.

Account

Bcs Wealth Management Eli Lilly & CO Transaction History